Syngene likely to go public this July

After months of speculation, Biocon’s in-house CRO, Syngene, may go public in July this year.


(Photo Courtesy:

"The DRHP (Draft Red Herring Prospectus) is likely to be filed today," a Syngene spokesperson told Business Standard.

Incorporated in 1993, Syngene offers integrated discovery and development services to pharma and biotech, agro-chemical as well as other industries.

Recently in 2015, Clinigene International, a fully-owned subsidiary of Syngene, involved in drug discovery and development CRO, was incorporated into Syngene.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box


GST: Boon or Bane for Healthcare?

Send this article by email